ACCESS Health China and Singapore Economic Development Board establish the China-Singapore/ASEAN Biomedical Industry Platform

ACCESS Health China initiative, ASK Health is collaborating with the Singapore Economic Development Board to jointly establish the China-Singapore/ASEAN Biomedical Industry Platform. The platform will assist Chinese pharmaceutical and MedTech companies looking to expand to the ASEAN market and the wider APAC market.

In recent years, Chinese pharmaceutical and MedTech companies have become increasingly interested in expanding to the ASEAN market. As ASEAN’s biotech hub, Singapore is well positioned to be an entry point and gateway for the Chinese biomedical companies to the ASEAN market.